730 related articles for article (PubMed ID: 19172514)
21. [Relationship of state of aggregation with various biochemical parameters--tested on platelet concentrates from buffy coats after 5 days of storage].
Posch U; Kokelj M; Kostner GM; Lanzer G
Beitr Infusionsther Transfusionsmed; 1994; 32():78-80. PubMed ID: 9480162
[TBL] [Abstract][Full Text] [Related]
22. Cytoskeletal reorganization after preparation of platelet concentrates, using the buffy coat method, and during their storage.
Estebanell E; Diaz-Ricart M; Lozano M; Mazzara R; Escolar G; Ordinas A
Haematologica; 1998 Feb; 83(2):112-7. PubMed ID: 9549921
[TBL] [Abstract][Full Text] [Related]
23. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
24. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
Schlagenhauf A; Kozma N; Leschnik B; Wagner T; Muntean W
Transfusion; 2012 Jun; 52(6):1253-9. PubMed ID: 22233332
[TBL] [Abstract][Full Text] [Related]
25. The platelet adhesion capacity to subendothelial matrix and collagen in a flow model during storage of platelet concentrates for 7 days.
Boomgaard MN; Gouwerok CW; Homburg CH; de Groot G; IJsseldijk MJ; de Korte D
Thromb Haemost; 1994 Oct; 72(4):611-6. PubMed ID: 7878640
[TBL] [Abstract][Full Text] [Related]
26. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
[TBL] [Abstract][Full Text] [Related]
27. In vitro assessment of platelet concentrates with multiple electrode aggregometry.
Shams Hakimi C; Hesse C; Wallén H; Boulund F; Grahn A; Jeppsson A
Platelets; 2015; 26(2):132-7. PubMed ID: 24999542
[TBL] [Abstract][Full Text] [Related]
28. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of platelet concentrates, with particular reference to Autopheresis C Plateletcell: correlation between dMPV and other tests for platelet function.
Vickers MV; Ip AH; Cutts M; Tandy NP; Seghatchian MJ
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):361-6. PubMed ID: 1909905
[TBL] [Abstract][Full Text] [Related]
30. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies.
Picker SM; Schneider V; Gathof BS
Transfusion; 2009 Jun; 49(6):1224-32. PubMed ID: 19220821
[TBL] [Abstract][Full Text] [Related]
31. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
32. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
Albanyan AM; Harrison P; Murphy MF
Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
[TBL] [Abstract][Full Text] [Related]
33. Preparation and storage of white blood cell-reduced split apheresis platelet concentrates for pediatric use.
van der Meer PF; Vrielink H; Pietersz RN
Transfusion; 2005 Feb; 45(2):223-7. PubMed ID: 15660831
[TBL] [Abstract][Full Text] [Related]
34. Platelet function testing during 5-day storage of single and random donor plateletpheresis.
Akay OM; Gündüz E; Başyiğit H; Gulbas Z
Transfus Apher Sci; 2007 Jun; 36(3):285-9. PubMed ID: 17602871
[TBL] [Abstract][Full Text] [Related]
35. [Changes in platelet concentrates from dogs due to storage. I. Platelet count in in vitro function].
Klein A; Adamik A; Mischke R
Berl Munch Tierarztl Wochenschr; 1999; 112(6-7):243-53. PubMed ID: 10472723
[TBL] [Abstract][Full Text] [Related]
36. [Platelet membrane glycoproteins in thrombocytapheresis and platelet concentrates].
Dittmann J; Riggert J; Wieding JU; Simson G; Köhler M
Beitr Infusionsther Transfusionsmed; 1994; 32():422-7. PubMed ID: 9480137
[TBL] [Abstract][Full Text] [Related]
37. Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system.
Palmer DS; Aye MT; Dumont L; Dumont D; McCombie N; Giulivi A; Rutherford B; Trudel E; Hashemi-Tavoularis S
Vox Sang; 1998; 75(2):115-23. PubMed ID: 9784664
[TBL] [Abstract][Full Text] [Related]
38. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
39. Platelet concentrates transfusion in cardiac surgery in relation to preoperative point-of-care assessment of platelet adhesion and aggregation.
Solomon C; Hartmann J; Osthaus A; Schöchl H; Raymondos K; Koppert W; Rahe-Meyer N
Platelets; 2010; 21(3):221-8. PubMed ID: 20158381
[TBL] [Abstract][Full Text] [Related]
40. [Blood fractionation based on the extraction of the buffy-coat layer. Analysis of our results].
Algora M; Torres P; Rodríguez MA; de la Calle C; Biurrún M; Nieto S; Ruiz M; Alonso MV
Sangre (Barc); 1995 Apr; 40(2):91-6. PubMed ID: 7784953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
